Isofol Medical AB (publ) publishes interim report, January–March 2023
GOTHENBURG, Sweden, May 3, 2023 - Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL), announced today that the company's interim report for January–March 2023 is now available, in Swedish, on the company's website, www.isofolmedical.com.The information in the press release is intended for investors. First quarter, January–March 2023 · Net revenue amounted to TSEK 721 (4,006) and other revenue to TSEK 23 (1) · The result for the period amounted to TSEK -14,395 (-47,874) · Earnings per share amounted to SEK -0.09 (-0.30) · Cash and cash equivalents on March 31 amounted to